business
Odyssey Therapeutics Climbs 11% After $304 Million US IPO
Odyssey Therapeutics Inc. shares jumped 11% in its trading debut, after the biopharmaceutical company raised $304 million in an upsized US initial public offering and private placement.
Read full story on Bloomberg Markets → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop